Jaguar Health, Inc.·4

Oct 10, 9:54 PM ET

MICEK JOHN 4

4 · Jaguar Health, Inc. · Filed Oct 10, 2024

Insider Transaction Report

Form 4
Period: 2024-10-08
MICEK JOHN
Director
Transactions
  • Award

    Stock option (right to buy)

    2024-10-08+26,50026,500 total
    Exercise: $1.29Exp: 2034-10-08Common Stock (26,500 underlying)
Footnotes (3)
  • [F1]Granted pursuant to the issuer's 2014 Stock Incentive Plan.
  • [F2]The option grant was approved by the issuer's board of directors on October 8, 2024.
  • [F3]The options will vest 100% on the first anniversary of the grant date, so long as the reporting person continues to serve on the board of directors of the issuer and Napo Therapeutics, S.p.A., the issuer's subsidiary, as applicable.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4